Perbedaan Organon Pharma Indonesia Tbk. dan Wijaya Karya (Persero) Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Wijaya Karya (Persero) Tbk. diperdagangkan di Rp204 (kapitalisasi pasar 8,13 T). Perbedaan utamanya: Wijaya Karya (Persero) Tbk. jauh lebih besar — sekitar 77,9× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | WIKA | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 8,13 T |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT Wijaya Karya (Persero) Tbk (Perseroan) established under Act No. 19 of 1960 jo Government Regulation No. 64 year 1961 on Establishment of State Company/PN Widjaja Karja March 29, 1961. Based on Government Regulation No. 64, the building company previously owned by Dutch named Naamloze Vennootschap Technische Handel Maatschappij en Bouwbedrijf Vis en Co. which has been subject to nationalization, was merged into the PN Widjaja Karja.Based on Goverment Regulation No. 40 dated July 22, 1971 PN. Widjaja Karja declared dissolved and transformed into Limited Liability Company (PERSERO).
Selengkapnya di halaman WIKA →